The IARC Perspective on Cervical Cancer Screening. Reply
N Engl J Med
.
2022 Feb 10;386(6):607-608.
doi: 10.1056/NEJMc2119177.
Authors
Béatrice Lauby-Secretan
1
,
Anne Mackie
2
,
Nicolas Wentzensen
3
Affiliations
1
International Agency for Research on Cancer, Lyon, France secretanb@iarc.fr.
2
U.K. Department of Health and Social Care, London, United Kingdom.
3
National Cancer Institute, Rockville, MD.
PMID:
35139285
DOI:
10.1056/NEJMc2119177
No abstract available
Publication types
Letter
Comment
MeSH terms
Early Detection of Cancer*
Female
Humans
Mass Screening
Uterine Cervical Neoplasms* / diagnosis
Grants and funding
001/WHO_/World Health Organization/International